title: Establishment of a human DAF/HRF20 double transgenic mouse line is not sufficient to suppress hyperacute rejection.
abstract: To solve the chronic donor organ shortage, the pig is considered to be a possible donor candidate for human transplantation. However, hyperacute rejection occurs due to the activation of the complement cascade. Therefore, the introduction of human complement inhibitors into animal cells has been proposed as a means to prevent such exologous complement activation. To investigate the extent to which complement inhibitors are resistant to human sera in discordant animals, we established transgenic mice lines which expressed either human decay-accelerating factor (DAF) and/or homologous restriction factor 20 (HRF20) using microinjection methods. Human sera were injected into (a) 10 control mice, (b) 10 DAF-transgenic mice, (c) 10 HRF20-transgenic mice, and (d) 10 DAF and HRF20-transgenic mice. The results showed that all the mice in groups a, b, and c died immediately after injection. Three of the mice in group d died, while seven survived but showed hyperpnea and low activity. The pathological findings of groups a, b, and c included severe coagulation; however, the survivors of group d showed less severe symptoms. The above findings thus suggest that both DAF and HRF20 tend to prevent complement activation to some extent; however, its effectiveness is not considered to be sufficient for clinical use in transplantation.
authors.affiliation: Second Department of Surgery, Nagoya University School of Medicine, Showa-ku, Japan.
authors.forename: C
authors.initials: C
authors.lastname: Koike
authors.forename: K
authors.initials: K
authors.lastname: Isobe
authors.forename: I
authors.initials: I
authors.lastname: Nakashima
authors.forename: H
authors.initials: H
authors.lastname: Okada
authors.forename: S
authors.initials: S
authors.lastname: Hayashi
authors.forename: I
authors.initials: I
authors.lastname: Yokoyama
authors.forename: H
authors.initials: H
authors.lastname: Takagi
mesh_terms: D000818:Animals; D015703:Antigens, CD; D000953:Antigens, Protozoan; D018957:CD59 Antigens; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D008562:Membrane Glycoproteins; D051379:Mice; D008822:Mice, Transgenic; D015800:Protozoan Proteins; D014183:Transplantation, Heterologous
chemical_list: D015703:Antigens, CD; D000953:Antigens, Protozoan; D018957:CD59 Antigens; D008562:Membrane Glycoproteins; D015800:Protozoan Proteins; C082910:TDAF protein, Trypanosoma cruzi